Rare Genes Can Raise Odds for Obesity 6-Fold
By Dennis Thompson HealthDay Reporter
THURSDAY, April 4, 2024 -- Two newly discovered genetic variations can have a powerful effect on a person’s risk for obesity, a new report says.
Variants in the gene BSN, also known as Bassoon, can increase risk of obesity as much as sixfold, researchers report April 4 in the journal Nature Genetics.
These variants affect about 1 in every 6,500 adults, researchers said.
Variants of the APBA1 gene also are associated with increased obesity risk, results show.
“We have identified two genes with variants that have the most profound impact on obesity risk at a population level we’ve ever seen,” said researcher Giles Yeo, a professor with the Medical Research Council’s Metabolic Diseases Unit at Cambridge University.
Previous genetic variants associated with obesity have been linked to the brain pathways normally associated with appetite regulation, known as the leptin-melanocortin pathway, researchers said.
Interestingly, neither the BSN nor the APBA1 gene are known to be involved in that brain pathway, researchers said.
Instead, prior studies have found that these genes play a role in the transmission of signals between brain cells -- suggesting that age-related brain declines might affect appetite control.
Further, neither gene is associated with childhood obesity risk, researchers said.
For the study, researchers used data from the UK Biobank genetic research project to perform genetic sequencing of body mass index in more than a half-million people.
They found that the BSN gene variants also had other health effects, such as increasing risk of type 2 diabetes and non-alcoholic fatty liver disease.
“The genetic variants we identify in BSN confer some of the largest effects on obesity, type 2 diabetes and fatty liver disease observed to date and highlight a new biological mechanism regulating appetite control,” researcher John Perry, a professor at Cambridge, said in a university news release.
Sources
- University of Cambridge, news release, April 4, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Texas Rancher Developed Anthrax From Butchered Lamb Meat
FRIDAY, June 7, 2024 -- Anthrax disease in humans is rare and when it does occur, it's usually during hot, dry summers. That's why the case of a Texas rancher who developed...
Could Brain 'Overgrowth' Contribute to Autism?
FRIDAY, June 7, 2024 -- Severe forms of autism could be linked to overgrowth of the brain’s outer layer that starts while a baby is in the womb, a new study finds. Toddlers...
Patient in Mexico Dies From First Known Human Infection of H5N2 Strain of Bird Flu
THURSDAY, June 6, 2024 -- A 59-year-old person in Mexico is the first human in the world known to be infected with the H5N2 strain of avian flu, and the patient died of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
